Krystal Biotech
KRYS
#2449
Rank
NZ$12.57 B
Marketcap
NZ$433.70
Share price
1.50%
Change (1 day)
52.40%
Change (1 year)

Earnings for Krystal Biotech (KRYS)

Earnings in 2025 (TTM): NZ$0.27 Billion

According to Krystal Biotech's latest financial reports the company's current earnings are NZ$0.37 Billion. In 2024 the company made an earning of NZ$0.17 Billion, an increase over its 2023 earnings that were of NZ$22.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Krystal Biotech from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.27 B54.53%
2024 NZ$0.17 B700.38%
2023 NZ$22.07 M-110.98%
2022 -NZ$0.21 Billion72.56%
2021 -NZ$0.12 Billion111.4%
2020 -NZ$55.13 Million45.85%
2019 -NZ$37.8 Million85.28%
2018 -NZ$20.4 Million149.78%
2017 -NZ$8.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion-193.55%๐Ÿ‡บ๐Ÿ‡ธ USA